Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: alemtuzumab; Biological: anti-thymocyte globulin; Biological: filgrastim; Biological: rituximab; Biological: therapeutic allogeneic lymphocytes; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: methotrexate; Drug: mycophenolate mofetil; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy
Sponsor: German CLL Study Group
Completed - verified April 2007
Interventions: Biological: alemtuzumab; Biological: anti-thymocyte globulin; Biological: filgrastim; Biological: rituximab; Biological: therapeutic allogeneic lymphocytes; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: methotrexate; Drug: mycophenolate mofetil; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy
Sponsor: German CLL Study Group
Completed - verified April 2007